thiazoles has been researched along with Basal Ganglia Diseases in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 15 (57.69) | 29.6817 |
| 2010's | 10 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cucchiaro, J; Hsu, C; Kalali, AH; Loebel, A; Pikalov, A; Potkin, SG; Sarma, K; Xu, L | 1 |
| Cucchiaro, J; Hsu, J; Loebel, A; Nasrallah, HA; Phillips, D; Silva, R; Xu, J | 1 |
| Hamada, K; Ishii, K; Iwata, A; Mannen, T; Murayama, S; Saito, Y; Sakurai, Y; Sonoo, M; Sugimoto, I; Tsuji, S | 1 |
| Kono, B; Kurosawa, H; Takei, D; Yomiya, K | 1 |
| Beszlej, A; Bienkowski, P; Frydecka, D; Grzywacz, A; Mierzejewski, P; Samochowiec, A; Samochowiec, J; Trześniowska-Drukała, B; Tybura, P | 1 |
| Brooks, KR; Kram, BL; Kram, SJ | 1 |
| Fabbri, C; Kato, M; Kinoshita, T; Koshikawa, Y; Nonen, S; Okugawa, G; Sakai, S; Serretti, A; Sunada, N; Takekita, Y; Wakeno, M | 1 |
| Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Thys, E; van Veelen, NM; Verkes, RJ | 1 |
| Kato, M; Kinoshita, T; Kishimoto, T; Koh, J; Matsumoto, N; Morikawa, M; Okugawa, G; Shinosaki, K; Wakeno, M; Yoneda, H | 1 |
| Christodoulou, C; Douzenis, A; Gournellis, R; Lykouras, LP; Rizos, E | 1 |
| Li, YM; Ou, JJ; Wu, RR; Zhao, JP | 1 |
| Bachinsky, M; Cavus, I; Karayal, ON; Kolluri, S; Sachs, GS; Vanderburg, DG | 1 |
| Koyama, T; Nakagawa, S | 1 |
| Daniel, DG; Romano, SJ; Simpson, G; Weiden, PJ | 1 |
| Sathpathy, S; Winsberg, B | 1 |
| Cancro, R; Chuang, L; Jacobson, J; Lusskin, SI | 1 |
| Johnson, CE; Mason, MN; Piasecki, M | 1 |
| Dubois, D | 1 |
| Matsui-Sakata, A; Ohtani, H; Sawada, Y | 1 |
| Berg, PH; Breier, A; Cavazzoni, P; Gattaz, WF; Kane, JM; Naber, D; Roychowdhury, SM; Thakore, JH; Walker, DJ | 1 |
| Bowie, C; Green, MF; Harvey, PD; Loebel, A | 1 |
| Colasanti, A; Dragogna, F; Fiorentini, A; Mauri, MC; Papa, P; Rossattini, M; Valli, A; Volonteri, LS | 1 |
| Washburn, CF | 1 |
| Domino, EF; Kohno, Y; Ni, L; Sasa, M; Zhang, H | 1 |
| Ohno, Y | 1 |
| Caley, CF; Cooper, CK | 1 |
5 review(s) available for thiazoles and Basal Ganglia Diseases
| Article | Year |
|---|---|
[Extrapyramidal syndrome].
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dystonia; Humans; Indoles; Isoindoles; Parkinsonian Disorders; Quetiapine Fumarate; Receptors, Muscarinic; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Syndrome; Thiazoles | 2003 |
Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
Topics: Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Cardiomyopathies; Child; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Drug Interactions; Drug Overdose; Dry Eye Syndromes; Humans; Hyperlipidemias; Hypotension; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Seizures; Thiazoles | 2005 |
Problems with CATIE. Phase 1: Looking back--what the clinician needs to know.
Topics: Antidepressive Agents, Second-Generation; Basal Ganglia Diseases; Benzodiazepines; Clinical Trials, Phase I as Topic; Cost-Benefit Analysis; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risk; Risperidone; Schizophrenia; Thiazoles | 2008 |
[Pharmacological characteristics of perospirone hydrochloride, a novel antipsychotic agent].
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Humans; Indoles; Isoindoles; Schizophrenia; Serotonin Antagonists; Thiazoles | 2000 |
Ziprasidone: the fifth atypical antipsychotic.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Headache; Humans; Injections, Intramuscular; Long QT Syndrome; Nausea; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2002 |
11 trial(s) available for thiazoles and Basal Ganglia Diseases
| Article | Year |
|---|---|
Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Analysis of Variance; Antipsychotic Agents; Basal Ganglia Diseases; Body Mass Index; Body Weight; Dibenzothiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Models, Statistical; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Waist Circumference; Young Adult | 2013 |
Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; International Cooperation; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Catechol O-Methyltransferase; Dopamine Plasma Membrane Transport Proteins; Female; Genotype; GluK3 Kainate Receptor; Humans; Male; Middle Aged; Monoamine Oxidase; Olanzapine; Overweight; Perazine; Piperazines; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Kainic Acid; Schizophrenia, Paranoid; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Weight Gain; Young Adult | 2014 |
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Partial Agonism; Female; Humans; Isoindoles; Male; Middle Aged; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Young Adult | 2015 |
Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial.
Topics: Adult; Alanine Transaminase; Antipsychotic Agents; Aspartate Aminotransferases; Basal Ganglia Diseases; Benzodiazepines; Biperiden; Blood Glucose; Body Weight; Cholesterol; Chronic Disease; Electrocardiography; Female; Humans; Male; Muscarinic Antagonists; Olanzapine; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychometrics; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Triglycerides; Young Adult | 2011 |
Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Female; Humans; Isoindoles; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2009 |
Efficacy and tolerability of ziprasidone vs. olanzapine in naive first-episode schizophrenia: a 6-week, randomized, open-label, flexible-dose study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comparative Effectiveness Research; Dose-Response Relationship, Drug; Drug Monitoring; Episode of Care; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; Weight Gain | 2012 |
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Antimanic Agents; Basal Ganglia Diseases; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome; Valproic Acid; Young Adult | 2012 |
Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Body Weight; Female; Health Status Indicators; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Withholding Treatment | 2003 |
Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.
Topics: Adult; Age of Onset; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Blood Glucose; Double-Blind Method; Drug Administration Schedule; Fasting; Female; Humans; Lipids; Male; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome | 2005 |
Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Chromatography, High Pressure Liquid; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles | 2007 |
10 other study(ies) available for thiazoles and Basal Ganglia Diseases
| Article | Year |
|---|---|
Progressive apraxic agraphia with micrographia presenting as corticobasal syndrome showing extensive Pittsburgh compound B uptake.
Topics: Aged; Agraphia; Aniline Compounds; Apolipoproteins E; Apraxias; Basal Ganglia Diseases; Brain; Cerebral Cortex; Cysteine; Disease Progression; Executive Function; Female; Handwriting; Humans; Image Processing, Computer-Assisted; Intelligence Tests; Neurodegenerative Diseases; Neurologic Examination; Neuropsychological Tests; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reading; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2013 |
[A study on the antiemetic effect and extrapyramidal symptoms of prochlorperazine versus perospirone for the control of nausea and vomiting due to opioid introduction].
Topics: Antiemetics; Basal Ganglia Diseases; Female; Humans; Isoindoles; Male; Middle Aged; Nausea; Neoplasms; Opioid-Related Disorders; Palliative Care; Prochlorperazine; Retrospective Studies; Thiazoles; Vomiting | 2013 |
Implications of atypical antipsychotic prescribing in the intensive care unit.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Basal Ganglia Diseases; Benzodiazepines; Cohort Studies; Delirium; Disorders of Excessive Somnolence; Female; Humans; Inappropriate Prescribing; Intensive Care Units; Male; Middle Aged; Olanzapine; Patient Discharge; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Survivors; Thiazoles | 2015 |
Tardive dyskinesia in a patient treated with quetiapine.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Sulpiride; Thiazoles | 2009 |
Extrapyramidal symptoms in children on atypical antipsychotic drugs.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Child; Dibenzothiazepines; Female; Humans; Male; Piperazines; Quetiapine Fumarate; Thiazoles | 2003 |
Prolactin elevation with ziprasidone.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Comorbidity; Depression, Postpartum; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome | 2004 |
Ziprasidone-induced acute dystonia.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Dystonia; Humans; Male; Middle Aged; Piperazines; Schizophrenia, Paranoid; Thiazoles | 2005 |
Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone; Schizophrenia; Thiazoles | 2005 |
The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Cognition Disorders; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2006 |
Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.
Topics: Animals; Antiparkinson Agents; Azepines; Basal Ganglia Diseases; Behavior, Animal; Benzazepines; Benzothiazoles; Dopamine Agents; Dopamine Agonists; Drug Interactions; Female; Macaca nemestrina; MPTP Poisoning; Parkinson Disease, Secondary; Pramipexole; Sleep; Thiazoles | 1997 |